Product Description
The global cardiac output monitoring market was valued at nearly $1.2 billion in 2024. This is expected to increase over the forecast period at a CAGR of 4.2% to reach nearly $1.6 billion.
The full report suite on the global market for cardiac output (CO) monitor includes cardiac output monitors, cardiac output sensors, and pulmonary-artery catheters.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL CARDIAC OUTPUT MONITORING MARKET TRENDS
The number of open-heart procedures, namely, coronary artery bypass graft (CABG) procedures, is expected to decrease over the forecast period. This reduces the installation of pulmonary artery catheters (PACs) in surgery and is supported by efforts on the part of hospitals to adopt less-invasive technologies. This specifically impacts the invasive CO market, which is set to decrease over the forecast period.
GLOBAL CARDIAC OUTPUT MONITORING MARKET SHARE INSIGHT
Becton Dickinson (BD) led the CO monitoring market after its acquisition of Edwards Lifesciences’ critical care business unit for $4.2 billion in September 2024. Although Edwards Lifesciences’ critical care business unit was slightly impacted during the sale due to the discontinued operations in the third quarter of 2024, BD remains as the market leader, and will continue to lead the cardiac output monitoring market in future years.
Baxter was the second-leading competitor in the total CO monitoring market, a position attributable to its significance in non-invasive monitoring. The company entered the market in 2019 through the acquisition of Cheetah Medical, a leading provider of non-invasive hemodynamic monitoring technologies.
Getinge was the third-leading competitor in the total CO monitoring market as a result of its significant activity in the minimally invasive monitoring segment. Through its fully owned subsidiary, Pulsion Medical, the company offered the PiCCO02™ device with CO and continuous central venous oxygen saturation monitoring capabilities.
GLOBAL CARDIAC OUTPUT MONITORING MARKET SEGMENTATION SUMMARY
- Output Monitoring
- Output Sensor
- Pulmonary Artery Catheter
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America(Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
